Related Experiment Video
Updated: Apr 7, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Microbiome in connective tissue diseases associated interstitial lung disease
Francesco Puppo1, Roberto G Carbone1
1Department of Internal Medicine, University of Genoa, Genoa, Italy.
Dysbiosis, an imbalance in the gut microbiome, may influence interstitial lung diseases (ILD) in connective tissue diseases (CTD). Further research is needed to understand this gut-lung axis connection and explore probiotic therapies for CTD-ILD.
Area of Science:
- Microbiology
- Immunology
- Pulmonology
Background:
- The human microbiome, a complex community of microorganisms, plays a crucial role in host health.
- Dysbiosis, or microbiome imbalance, is linked to inflammation and the pathogenesis of various diseases, including connective tissue diseases (CTD).
- Interstitial lung diseases (ILD) are characterized by lung fibrosis and are a significant cause of mortality in CTD patients.
Purpose of the Study:
- To review current knowledge on the role of the microbiome in connective tissue disease-associated interstitial lung diseases (CTD-ILD).
- To focus on clinical lung aspects and potential therapeutic strategies related to dysbiosis in CTD-ILD.
- To highlight the incomplete understanding of the gut-lung axis in CTD-ILD pathogenesis.
Main Methods:
- This review synthesizes existing literature on the microbiome in CTD-ILD.
- It examines the association between gut dysbiosis and ILD development.
- The review discusses clinical implications and therapeutic options, including probiotics.
Main Results:
- Altered lung microbiome and high microbial load are associated with poorer prognosis and acute exacerbations in CTD-ILD patients.
- Specific CTD subtypes, such as rheumatoid arthritis, systemic sclerosis, and dermatomyositis, show particular associations with lung microbiome changes.
- The gut-lung axis connection in CTD-ILD development requires further investigation.
Conclusions:
- Dysbiosis may contribute to the pathogenesis of CTD-ILD, impacting disease progression and outcomes.
- Probiotics are being considered as a potential supportive therapy for CTD-ILD by modulating gut flora.
- More research is essential to fully elucidate the relationship between dysbiosis and CTD-ILD and to validate therapeutic interventions.
More Related Videos
Related Concept Videos
Microbiota of the Respiratory Tract
Microbiome of the Eye
Microbiota of the Large Intestine
Introduction to Connective Tissues
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...

